These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3495903)

  • 1. Vitamin K counteracts the effect of warfarin in liver but not in bone.
    Price PA; Kaneda Y
    Thromb Res; 1987 Apr; 46(1):121-31. PubMed ID: 3495903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.
    Hara K; Kobayashi M; Akiyama Y
    J Bone Miner Metab; 2005; 23(5):366-72. PubMed ID: 16133686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K is no antagonist for the action of warfarin in rat osteosarcoma UMR 106.
    Ulrich MM; Knapen MH; Herrmann-Erlee MP; Vermeer C
    Thromb Res; 1988 Apr; 50(1):27-32. PubMed ID: 3165226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin and bone: implications for rational strategies to selectively antagonize the action of vitamin K in target tissues.
    Price PA
    Adv Exp Med Biol; 1987; 214():55-66. PubMed ID: 3499056
    [No Abstract]   [Full Text] [Related]  

  • 5. The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin.
    Nishimoto SK; Price PA
    J Biol Chem; 1985 Mar; 260(5):2832-6. PubMed ID: 3871773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats.
    Cottrell S; Andrews CM; Clayton D; Powell CJ
    Food Chem Toxicol; 1994 Jul; 32(7):589-94. PubMed ID: 8045471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.
    Barone LM; Aronow MA; Tassinari MS; Conlon D; Canalis E; Stein GS; Lian JB
    J Cell Physiol; 1994 Aug; 160(2):255-64. PubMed ID: 8040186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats.
    Morishima Y; Kamisato C; Honda Y; Furugohri T; Shibano T
    Thromb Res; 2013 Jan; 131(1):59-63. PubMed ID: 22999414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
    Byars TD; Greene CE; Kemp DT
    Am J Vet Res; 1986 Oct; 47(10):2309-12. PubMed ID: 3777660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair.
    Shimizu T; Takahata M; Kameda Y; Hamano H; Ito T; Kimura-Suda H; Todoh M; Tadano S; Iwasaki N
    Bone; 2014 Jul; 64():95-101. PubMed ID: 24731926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K.
    Andersen P; Godal HC
    Acta Med Scand; 1975 Oct; 198(4):269-70. PubMed ID: 1189983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium warfarin on vitamin K-dependent proteins and skeletal development in the rat fetus.
    Feteih R; Tassinari MS; Lian JB
    J Bone Miner Res; 1990 Aug; 5(8):885-94. PubMed ID: 2239372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K: the coagulation vitamin that became omnipotent.
    Cranenburg EC; Schurgers LJ; Vermeer C
    Thromb Haemost; 2007 Jul; 98(1):120-5. PubMed ID: 17598002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic warfarin use and the extrahepatic functions of vitamin K-dependent proteins.
    Donaldson CJ; Harrington DJ
    Br J Biomed Sci; 2017 Oct; 74(4):163-169. PubMed ID: 28657840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of beta-lactam antibiotics and heterocyclic thiol compounds on vitamin K-dependent carboxylation activity and blood coagulation factors in vitamin K-deficient rats.
    Oka T; Touchi A; Harauchi T; Takano K; Yoshizaki T; Matsubara T
    Biochem Pharmacol; 1988 May; 37(10):2091-5. PubMed ID: 3377812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture healing and osteocalcin metabolism in vitamin K deficiency.
    Einhorn TA; Gundberg CM; Devlin VJ; Warman J
    Clin Orthop Relat Res; 1988 Dec; (237):219-25. PubMed ID: 3263905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
    Wallin R; Rossi F; Loeser R; Key LL
    Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.